Literature DB >> 16102748

The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes.

Reginald Liew1, Mark A Stagg, Kenneth T MacLeod, Peter Collins.   

Abstract

Epidemiological evidence suggests that moderate consumption of red wine may be cardioprotective, although the precise mechanism(s) responsible remains poorly understood. We hypothesized that the red wine polyphenol, resveratrol, may exert direct actions on the heart and thus potentially contribute to cardioprotection. We show that resveratrol acutely decreases Ca2+ transient amplitude in isolated cardiac myocytes. Intriguingly, resveratrol simultaneously increases cell shortening in half the cells tested, while decreasing shortening in the other half. The former could be attributed to heightened myofilament Ca2+ sensitivity. This was no longer observed in myocytes that had been incubated with the oestrogen receptor antagonist, ICI 182,780, suggesting an oestrogen-receptor dependent mechanism of action. In addition, resveratrol significantly decreased action potential duration and the peak L-type Ca2+ current. Our findings provide evidence that resveratrol exerts multiple direct actions on cardiac myocytes, the net result of which is no overall change in cell contraction. The clinical significance of these results remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16102748     DOI: 10.1016/j.ejphar.2005.06.017

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Structure of trans-resveratrol in complex with the cardiac regulatory protein troponin C.

Authors:  Sandra E Pineda-Sanabria; Ian M Robertson; Brian D Sykes
Journal:  Biochemistry       Date:  2011-01-27       Impact factor: 3.162

2.  Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?

Authors:  Henry Sutanto; Dobromir Dobrev; Jordi Heijman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-20       Impact factor: 3.000

3.  Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

Authors:  C H R Wallace; I Baczkó; L Jones; M Fercho; P E Light
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 4.  Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Authors:  Belma Turan; Erkan Tuncay; Guy Vassort
Journal:  J Bioenerg Biomembr       Date:  2012-04       Impact factor: 2.945

Review 5.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

6.  Regulation of beta adrenoceptor-mediated myocardial contraction and calcium dynamics by the G protein-coupled estrogen receptor 1.

Authors:  Victoria Whitcomb; Eric Wauson; Daniel Christian; Sarah Clayton; Jennifer Giles; Quang-Kim Tran
Journal:  Biochem Pharmacol       Date:  2019-11-21       Impact factor: 5.858

7.  Effects of resveratrol and nebivolol on isolated vascular and cardiac tissues from young rats.

Authors:  Candice Pullen; Fiona R Coulson; Andrew Fenning
Journal:  Adv Pharmacol Sci       Date:  2014-02-20

8.  Extracts and Fractions from Edible Roots of Sechium edule (Jacq.) Sw. with Antihypertensive Activity.

Authors:  Galia Lombardo-Earl; Rubén Roman-Ramos; Alejandro Zamilpa; Maribel Herrera-Ruiz; Gabriela Rosas-Salgado; Jaime Tortoriello; Enrique Jiménez-Ferrer
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-09       Impact factor: 2.629

9.  Resveratrol attenuates inflammation-induced hyperexcitability of trigeminal spinal nucleus caudalis neurons associated with hyperalgesia in rats.

Authors:  Kenta Sekiguchi; Shiori Takehana; Eri Shibuya; Nichiwa Matsuzawa; Shiori Hidaka; Yurie Kanai; Maki Inoue; Yoshiko Kubota; Yoshihito Shimazu; Mamoru Takeda
Journal:  Mol Pain       Date:  2016-04-11       Impact factor: 3.395

10.  Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension.

Authors:  Judith Bernal-Ramírez; Christian Silva-Platas; Carlos Jerjes-Sánchez; Martín R Ramos-González; Eduardo Vázquez-Garza; Héctor Chapoy-Villanueva; Alicia Ramírez-Rivera; Ángel Zarain-Herzberg; Noemi García; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2021-06-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.